No more than 15 authors can be listed.Please ensure the authors are listed in the right order.If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.
Rifampicin-resistant tuberculosis (RR-TB) and non-small cell lung cancer (NSCLC) rarely coexist but pose diagnostic and therapeutic challenges in tuberculosis-endemic settings due to overlapping features. Oncologic emergencies such as superior vena cava (SVC) syndrome and tumor lysis syndrome (TLS) further complicate management; radiotherapy-induced TLS is exceptionally rare in solid tumors. We report a 57-year-old male with concurrent RR-TB and metastatic NSCLC complicated by SVC syndrome and early radiation-induced TLS, resulting in a rapidly progressive and fatal course.
The patient presented with 30 pack-year smoking history and occupational paint exposure presented with progressive dyspnea, productive cough, and weight loss. Chest X-ray revealed bilateral upper lobe infiltrates and massive right pleural effusion, for which chest tube thoracotomy was done. Sputum polymerase chain reaction confirmed Mycobacterium tuberculosis with rifampicin resistance (RR-TB), treated with Bedaquiline, Pretomanid, Linezolid, Moxifloxacin (BPaLM) regimen. Chest Computed tomography revealing a bulky right apical lung mass (10.4 × 5.5 × 6.3 cm) with mediastinal invasion causing SVC compression, with metastatic involvement of the liver, bones, and pleura. CT-guided biopsy confirmed NSCLC (squamous cell carcinoma vs adenocarcinoma). Following a single fraction of radiotherapy (5 Gy), he developed TLS, evidenced by hyperuricemia, hyperkalemia, hyperphosphatemia and acute kidney injury. Despite management, patient’s advanced malignancy, severe cachexia, and poor physiologic reserve led to rapid deterioration and death.
RR-TB and NSCLC may coexist in high-risk populations and often present with overlapping clinical and radiologic features, contributing to delayed diagnosis and advanced disease at presentation. The presence of SVC syndrome necessitates urgent intervention; however, this case demonstrates that even low-dose radiotherapy may precipitate TLS in patients with high tumor burden. Although rare, radiotherapy-induced TLS carries significant mortality and is underrecognized in solid tumors. This case highlights that timely recognition and vigilant metabolic monitoring are crucial, as the radiosensitivity of NSCLC may predispose to potentially fatal complications.